Market Overview:
The global jet-based needle-free injectors market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for needle-free injectors due to their benefits over traditional needles and syringes. In addition, the increasing prevalence of chronic diseases is also contributing to the growth of this market. Based on type, disposable needle-free injectors are expected to account for a larger share of the global jet-based needle-free injectors market than reusable needle-free injectors during the forecast period. This can be attributed to their low cost and easy availability as compared with reusable needle-free injectors. Based on application, hospitals and clinics are expected to account for a larger share of the global jet-based needle free injection market than home care settings duringthe forecast period owingto th ehigher incidenceof chronic diseases in hospitals and clinics as compared with home care settings .
Product Definition:
Jet-based needle-free injectors are devices that use a jet of fluid to penetrate the skin and deliver medication or other substances beneath the skin. The jet is created by pressurized gas, which is forced through a small opening in the tip of the injector. This type of injector is often used to administer vaccines or other medications to large numbers of people quickly and efficiently.
Disposable Needle-Free Injectors:
Disposable needle-free injectors are devices that do not require a needle to dispense the medication. The device consists of a cup or chamber where the drug is placed and then, through pressure generated by an electric current passed through it, the drug is forced into a syringe.
The major advantage of this system over other systems is that there are no sharp needles in these injectors; instead, they use soft plastic tubing as their needles.
Reusable Needle-Free Injectors:
Reusable needle-free injectors are devices used to inject medication into the patient's body without using a reusable syringe or a needle. The device consists of an injection pen, which is connected by tubing to an attached drug reservoir. The drug is released from the reservoir either when the trigger is pressed or when the unit gets empty.
The major advantage offered by these devices over traditional methods of injecting drugs includes reduced risk of needlestick injuries.
Application Insights:
Based on application, the global jet-based needle-free injectors market is segmented into hospitals and clinics, home care settings, research laboratories, pharmaceutical and biotechnological companies and others. The hospitals and clinics segment dominated the market in 2017 owing to factors such as increasing prevalence of infectious diseases along with high demand for immunization procedures. Moreover, an increase in cancer cases has also boosted product demand in this segment over the recent years.
The pharmaceutical industry is anticipated to be one of the fastest growing segments during the forecast period due to factors such as government initiatives encouraging R&D investments coupled with a rise in M&A activities by major players within this industry.
Regional Analysis:
North America dominated the global market in 2017. The presence of sophisticated healthcare infrastructure, high adoption rate of advanced technologies, and increasing demand for novel drug delivery systems are some major factors responsible for its large share. Moreover, the high cost of medical devices is another factor driving their adoption in this region. According to a study published by Merck & Co., Inc.
Asia Pacific is expected to be one of the fastest growing regions over the forecast period owing to rising diabetic population and awareness about available treatment options among patients as well as practitioners. In addition, continuous technological advancements coupled with economic development will drive regional growth further down the road due to increased disposable income levels and improved standard of living resulting from rapid urbanization processes taking place across various countries such as China India Japan South Korea Thailand Vietnam Indonesia Philippines etc.
Growth Factors:
- Increasing demand for needle-free injections in the medical sector as a result of growing awareness about the benefits of such injections over traditional needles.
- Rising prevalence of chronic diseases, which is leading to an increase in the number of people requiring regular injections for treatment.
- Growing demand for jet-based needle-free injectors from the pharmaceutical and biotechnology industries due to their ability to deliver high doses of drugs with precision and accuracy.
- Technological advancements that are making jet-based needle-free injectors more compact, portable, and user friendly, thereby increasing their adoption among consumers.
- Government initiatives aimed at promoting the use of needle-free injections as a means to reduce healthcare costs and improve patient outcomes
Scope Of The Report
Report Attributes
Report Details
Report Title
Jet-Based Needle-Free Injectors Market Research Report
By Type
Disposable Needle-Free Injectors, Reusable Needle-Free Injectors
By Application
Hospitals and Clinics, Home Care Settings, Research Laboratories, Pharmaceutical and Biotechnological Companies, Others
By Companies
PharmaJet, Antares Pharma, Endo International PLC, Injex Pharma AG, European Pharma Group(InsuJet), Portal Instruments, PenJet Corporation, Crossject, J-Tip
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
211
Number of Tables & Figures
148
Customization Available
Yes, the report can be customized as per your need.
Global Jet-Based Needle-Free Injectors Market Report Segments:
The global Jet-Based Needle-Free Injectors market is segmented on the basis of:
Types
Disposable Needle-Free Injectors, Reusable Needle-Free Injectors
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Clinics, Home Care Settings, Research Laboratories, Pharmaceutical and Biotechnological Companies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- PharmaJet
- Antares Pharma
- Endo International PLC
- Injex Pharma AG
- European Pharma Group(InsuJet)
- Portal Instruments
- PenJet Corporation
- Crossject
- J-Tip
Highlights of The Jet-Based Needle-Free Injectors Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Disposable Needle-Free Injectors
- Reusable Needle-Free Injectors
- By Application:
- Hospitals and Clinics
- Home Care Settings
- Research Laboratories
- Pharmaceutical and Biotechnological Companies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Jet-Based Needle-Free Injectors Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Jet-based needle-free injectors are a type of medical device that uses compressed air to deliver medication. They are inserted into the body through a vein in the arm and use tiny nozzles to shoot medicine directly into the bloodstream. This method is faster and less painful than traditional needles, and it is often used to give injections such as vaccines or medications for cancer treatment. Jet-based needle-free injectors have been shown to be more accurate than traditional needles, which can reduce the risk of infection or injury during injection.
Some of the key players operating in the jet-based needle-free injectors market are PharmaJet, Antares Pharma, Endo International PLC, Injex Pharma AG, European Pharma Group(InsuJet), Portal Instruments, PenJet Corporation, Crossject, J-Tip.
The jet-based needle-free injectors market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Jet-Based Needle-Free Injectors Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Jet-Based Needle-Free Injectors Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Jet-Based Needle-Free Injectors Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Jet-Based Needle-Free Injectors Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Jet-Based Needle-Free Injectors Market Size & Forecast, 2018-2028
4.5.1 Jet-Based Needle-Free Injectors Market Size and Y-o-Y Growth
4.5.2 Jet-Based Needle-Free Injectors Market Absolute $ Opportunity
Chapter 5 Global Jet-Based Needle-Free Injectors Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Jet-Based Needle-Free Injectors Market Size Forecast by Type
5.2.1 Disposable Needle-Free Injectors
5.2.2 Reusable Needle-Free Injectors
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Jet-Based Needle-Free Injectors Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Jet-Based Needle-Free Injectors Market Size Forecast by Applications
6.2.1 Hospitals and Clinics
6.2.2 Home Care Settings
6.2.3 Research Laboratories
6.2.4 Pharmaceutical and Biotechnological Companies
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Jet-Based Needle-Free Injectors Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Jet-Based Needle-Free Injectors Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Jet-Based Needle-Free Injectors Analysis and Forecast
9.1 Introduction
9.2 North America Jet-Based Needle-Free Injectors Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Jet-Based Needle-Free Injectors Market Size Forecast by Type
9.6.1 Disposable Needle-Free Injectors
9.6.2 Reusable Needle-Free Injectors
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Jet-Based Needle-Free Injectors Market Size Forecast by Applications
9.10.1 Hospitals and Clinics
9.10.2 Home Care Settings
9.10.3 Research Laboratories
9.10.4 Pharmaceutical and Biotechnological Companies
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Jet-Based Needle-Free Injectors Analysis and Forecast
10.1 Introduction
10.2 Europe Jet-Based Needle-Free Injectors Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Jet-Based Needle-Free Injectors Market Size Forecast by Type
10.6.1 Disposable Needle-Free Injectors
10.6.2 Reusable Needle-Free Injectors
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Jet-Based Needle-Free Injectors Market Size Forecast by Applications
10.10.1 Hospitals and Clinics
10.10.2 Home Care Settings
10.10.3 Research Laboratories
10.10.4 Pharmaceutical and Biotechnological Companies
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Jet-Based Needle-Free Injectors Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Jet-Based Needle-Free Injectors Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Jet-Based Needle-Free Injectors Market Size Forecast by Type
11.6.1 Disposable Needle-Free Injectors
11.6.2 Reusable Needle-Free Injectors
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Jet-Based Needle-Free Injectors Market Size Forecast by Applications
11.10.1 Hospitals and Clinics
11.10.2 Home Care Settings
11.10.3 Research Laboratories
11.10.4 Pharmaceutical and Biotechnological Companies
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Jet-Based Needle-Free Injectors Analysis and Forecast
12.1 Introduction
12.2 Latin America Jet-Based Needle-Free Injectors Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Jet-Based Needle-Free Injectors Market Size Forecast by Type
12.6.1 Disposable Needle-Free Injectors
12.6.2 Reusable Needle-Free Injectors
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Jet-Based Needle-Free Injectors Market Size Forecast by Applications
12.10.1 Hospitals and Clinics
12.10.2 Home Care Settings
12.10.3 Research Laboratories
12.10.4 Pharmaceutical and Biotechnological Companies
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Jet-Based Needle-Free Injectors Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Jet-Based Needle-Free Injectors Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Jet-Based Needle-Free Injectors Market Size Forecast by Type
13.6.1 Disposable Needle-Free Injectors
13.6.2 Reusable Needle-Free Injectors
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Jet-Based Needle-Free Injectors Market Size Forecast by Applications
13.10.1 Hospitals and Clinics
13.10.2 Home Care Settings
13.10.3 Research Laboratories
13.10.4 Pharmaceutical and Biotechnological Companies
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Jet-Based Needle-Free Injectors Market: Competitive Dashboard
14.2 Global Jet-Based Needle-Free Injectors Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 PharmaJet
14.3.2 Antares Pharma
14.3.3 Endo International PLC
14.3.4 Injex Pharma AG
14.3.5 European Pharma Group(InsuJet)
14.3.6 Portal Instruments
14.3.7 PenJet Corporation
14.3.8 Crossject
14.3.9 J-Tip
